DELRAY BEACH, Fla., Oct 15, 2014 (GLOBE NEWSWIRE via COMTEX) -- VeriTeQ Corporation ("VeriTeQ" or "Company") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the Company and its breast implant customer, Establishment Labs, S.A., ("EL") are hosting a physician conference in Salzburg, Austria on October 16, 2014, based on demand for EL's Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM).
As of mid-September, more than 1,000 women in Europe, Latin America and Asia have now received Motiva Implant Matrix(R) breast implants with Q Inside Safety Technology(TM). EL's Motiva Implant Matrix(R) Ergonomix(TM), VelvetSurface(R) PLUS, and SilkSurface(R) PLUS, all with VeriTeQ's Q Inside Safety Technology(TM), have received CE Mark approval.
VeriTeQ's FDA cleared Q Inside Safety Technology(TM) acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online databases to retrieve device-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology(TM) may also provide an extra level of protection to the patient in the event of a recall or other safety event.
"In conjunction with VeriTeQ, we have advanced Motiva breast implant technology to the 21 century," said EL's Chief Executive Officer Juan Jose Chacon-Quiros. "Patients and physicians are now able to choose our innovative products for enhanced safety and satisfaction."
The educational conference for plastic, aesthetic and reconstructive surgeons is being held at the Kavalierhaus Klessheim in Salzburg, Austria.
AI
